Table 1.

Study inclusion and exclusion criteria

Include	Exclude
Publisheda from January 2000 to February 2017	Publisheda before 2000
Focused on one or more LMICb	Focused on high-income country(ies)
Target population children under 5 years of age	Target population children over 5 years of age or unspecified
Intervention is any rotavirus vaccine delivered in any manner	N/A
Full-text paper	Abstracts, posters or presentations
1. Study self-described as a BIA 2. Other full economic evaluation (CEA or CUA)	1. Fiscal, revenue or cost-benefit analyses, or costing studies that do not capture both: (a) Costs of rotavirus vaccination; and (b) Cost savings 2. Studies that do not report either: (a) Novel analysis from primary data collection; or (b) Secondary analysis or modelling of primary data 3. Review, editorial, perspective or discussion pieces

BIA budget impact analysis, CEA cost-effectiveness analysis, CUA cost-utility analysis, LMIC low- and middle-income country, N/A not applicable

^a If unpublished, refers to date reported

^b Based on World Bank Analytical Classification using gross national income per capita (Atlas methodology), based on the World Bank’s fiscal year at the time of publication